EUR/USD
1.16683
0.017%
Gold
4589.83
-0.162%
Oil
60.228
0.976%
USD/JPY
158.889
0.463%
GBP/USD
1.34784
0.097%
GBP/JPY
214.163
0.568%
Real-time News
RIA Novosti: Russian forces have launched a large-scale attack on Ukraines energy and military industrial facilities.Morgan Stanley predicts that the overall inflation rate for the December CPI report, to be released later today, will reach 0.37% month-on-month and 2.7% year-on-year. Core inflation is expected to be 0.36% month-on-month and 2.8% year-on-year. Morgan Stanley cites two key reasons for this relatively hawkish forecast: firstly, the November survey data was collected later, and secondly, the inflation level in cities using the bi-monthly survey model is higher. According to their calculations, these two factors will push the December core inflation rate up by approximately 11 basis points. Overall, Morgan Stanley expects the report to show a significant rebound in price pressures after the recent period of weakness. This could reverse the market narrative that the "inflation decline is merely paused, not restarted."On January 13th, data from the China Automobile Dealers Association showed that in December 2025, the national used car market saw 1.8711 million transactions, a 7.15% increase month-on-month and a 1.53% decrease year-on-year, with a transaction value of 120.672 billion yuan. From January to December 2025, the cumulative used car transaction volume reached 20.108 million vehicles, a 2.52% increase year-on-year, with a cumulative transaction value of 1,289.79 billion yuan.Google will develop and manufacture high-end mobile phones in Vietnam this year.On January 13th, Bio-Thera Solutions announced that its second board of directors held its 18th meeting on October 8th, 2024, and approved the "Proposal on Signing an Authorization License, Production, Supply and Commercialization Agreement for BAT2206". According to the agreement, Bio-Thera Solutions recently received a one-time milestone payment of US$2.5 million from Jireh Pharmaceuticals. This payment further replenishes the companys cash reserves and supports the companys subsequent pipeline development and internationalization strategy. As of the date of this announcement, BAT2206 injection has been approved for marketing by the U.S. Food and Drug Administration and the European Medicines Agency, with the registered brand name STARJEMZA® in the U.S. and Usymro® in Europe; a marketing application has been submitted to the National Medical Products Administration of China and is currently under review.
